首页 › 基金 › ArrowMark Colorado Holdings LLC › BMRN
ArrowMark Colorado Holdings LLC 对 BMRN 的持仓历史
BIOMARIN PHARMACEUTICAL INC · 医疗保健
ArrowMark Colorado Holdings LLC 在 Q3 2026 的 13F 申报中披露持有 BMRN(BIOMARIN PHARMACEUTICAL INC)193,000 股,市值约 US$11.6M,约占其申报组合的 0.55%,在其申报持仓中市值排名第 47 位。 ArrowMark Colorado Holdings LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
ArrowMark Colorado Holdings LLC 对 BMRN 的持仓演变
ArrowMark Colorado Holdings LLC 于 Q3 2026 首次披露 BMRN 持仓:193,000 股(约 US$11.6M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 193.00K | $11.58M | 新进 |
关于 BMRN 与 13F 数据
BMRN(BIOMARIN PHARMACEUTICAL INC)属于医疗保健行业。我们追踪的基金中还有 26 只申报持有 BMRN,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), 维京环球投资 (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BMRN 的基金
- PRIMECAP MANAGEMENT CO/CA/ 14.99M 股 · $899.34M · Q3 2026
- 维京环球投资 7.62M 股 · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.62M 股 · $435.82M · Q2 2026
- Deep Track Capital, LP 6.37M 股 · $382.46M · Q3 2026
- Vestal Point Capital, LP 6.03M 股 · $344.75M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M 股 · $108.89M · Q2 2026
更多关于 ArrowMark Colorado Holdings LLC
常见问题
How long has ArrowMark Colorado Holdings LLC held BMRN?
ArrowMark Colorado Holdings LLC has disclosed BMRN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ArrowMark Colorado Holdings LLC's current position in BMRN?
As of Q3 2026, ArrowMark Colorado Holdings LLC holds 193.00K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $11.58M, representing 0.55% of its reported portfolio and ranking #47.
Has ArrowMark Colorado Holdings LLC been buying or selling BMRN?
In the latest 13F filing (Q3 2026), ArrowMark Colorado Holdings LLC newly opened its position in BMRN.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, 维京环球投资, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.